Detailed company information
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 04, 2026
Earnings Transcript for 2026 - Q1Released: May 07, 2026
Earnings Transcript for 2025 - Q4Released: Feb 24, 2026
Earnings Transcript for 2025 - Q3Released: Nov 04, 2025
Earnings Transcript for 2025 - Q2Released: Aug 05, 2025
Earnings Transcript for 2025 - Q1Released: May 06, 2025
Earnings Transcript for 2024 - Q4Released: Feb 25, 2025
Earnings Transcript for 2024 - Q3Released: Oct 29, 2024
Earnings Transcript for 2024 - Q2Released: Aug 06, 2024
Earnings Transcript for 2024 - Q1Released: Apr 30, 2024
Earnings Transcript for 2023 - Q4Released: Feb 22, 2024
Earnings Transcript for 2023 - Q3Released: Nov 01, 2023
Earnings Transcript for 2023 - Q2Released: Aug 01, 2023
Earnings Transcript for 2023 - Q1Released: May 02, 2023
Earnings Transcript for 2022 - Q4Released: Feb 21, 2023
Earnings Transcript for 2022 - Q3Released: Nov 01, 2022
Earnings Transcript for 2022 - Q2Released: Aug 02, 2022
Earnings Transcript for 2022 - Q1Released: May 03, 2022
Earnings Transcript for 2021 - Q4Released: Feb 28, 2022
Earnings Transcript for 2021 - Q3Released: Nov 14, 2021
Earnings Transcript for 2021 - Q2Released: Aug 10, 2021
Earnings Transcript for 2021 - Q1Released: May 11, 2021
GOSS Gossamer Bio, Inc.
Dafinchi
